The results showed that there is no significant difference in OCT-4 protein expression in patients with lymph node metastases compared with those without (OR = 1.45, 95% CI: 0.13–16.40, P=0.76, Figure 7). This evidence concerns the gene POU5F1 and metastatic malignant neoplasm in the lymph nodes.